Heron (Shangai) Pharmaceutical Science and Technology Co., Ltd.
2013, Nanjing Heron Pharmaceutical Science & Technology Company Limited is
an innovation-oriented company engaged in the research, development and
industrial production of new drugs
and first-time generic drugs in
China. Active Vitamin D derivatives
synthesis and Regulatory Service
with Technical Support are the two critical
characteristics of Heron Pharma. In 2016, Heron Pharma successfully landed
on the NEEQ Stock market (National
Equities Exchange and Quotations, Stock Code: 870070). We
established a GMP-certified production site for the scale-up and industrial
production of APIs, SODFs, soft gel capsule, small volume injections and
topical dosage forms. In 2018, an Accreditation Certificate of Foreign Drug Manufacturer was certified to Heron’s manufacturing base by Japan Pharmaceutical and Medical Devices
Agency (PMDA, No. AG10500666).
Heron (Shanghai) Pharmaceutical Science and Technology Co., Ltd. is a holding company of Nanjing Heron Pharma responsible for the export business of full range vitamin D analogs, including Alfacalcidol, Calcifediol Monohydrate, Calcipotriol Monohydrate, Calcitriol Anhydrous, Doxercalciferol, Eldecalcitol, Maxacalcitol, Paricalcitol and Tacalcitol Monohydrate. Their formulations can also be supplied upon request, including tablets, soft gel capsules, injections, ointment and cream. The intermediates and impurities reference substance are also available at USP, EP, BP or JP grade. We also take the distribution of below APIs: Bisacodyl, Dexlansoprazole Sodium, Nonoxynol, Tranilast, Vanillin and their formulations.
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Affiliated categories:||Capsules |Creams, Lotions, Ointments |Custom Manufacturing of Dosage Form Drugs More|
Our Top products
produced under GMP conditions, indicated for Gastric ulcer, duodenal ulcer and reflux esophagitisMore info
in compliance with the monographs of USP/EP/BP, produced under GMP conditions, indicated for Osteoporosis, Rickets and Osteomalacia.More info
News about Heron (Shangai) Pharmaceutical Science and Technology Co., Ltd.
7 Oct 2019
Heron Pharma attended CPhI China 2019
Many thanks to the customers visiting us on at booth E2G39 on CPhI China 2019. Let's meet again on CPhI China 2020 at W2B25 in Shanghai, Jun. 22-24th 2020.Read more
7 Oct 2019
Accreditation Certification of Foreign Drug Manufacturer from Japan PMDA
In 2018, an Accreditation Certificate of Foreign Drug Manufacturer was
certified to Heron’s manufacturing base by Japan Pharmaceutical and Medical
Devices Agency (PMDA, No. AG10500666).
Categories affiliated with Heron (Shangai) Pharmaceutical Science and Technology Co., Ltd.
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation